Breaking News, Collaborations & Alliances

Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific

CDMO Patheon to manufacture GI drug

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evoke Pharma, a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, has selected the Patheon division of Thermo Fisher Scientific as the commercial manufacturing partner for Gimoti, Evoke’s nasal delivery formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Thermo Fisher is a global contract development and manufacturing organization (CDMO) with specialized capabilities for the preparation, fil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters